Philogen revenue and financials
€22.25Change from previous close: +0.91%Absolute change: +€0.20
In the fiscal year ended December 2025, Philogen reported revenue of €314.33M (+324.79% year over year). Net income was €229.68M, a net margin of 73.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +324.79%
- 2025 vs 2024
- Net income growth
- +407.10%
- 2025 vs 2024
- Net margin
- 73.1%
- 2024: 61.2%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q4 2025 | Q2 2025 |
|---|---|---|
| Total assets | 437 | 159 |
| Current assets | 398 | 119 |
| Cash and equivalents | 127 | 11.2 |
| Short-term investments | 252 | 88.8 |
| Inventory | 3.0 | 4.3 |
| Net property, plant and equipment | 24.9 | 25.2 |
| Other intangible assets | 1.1 | 1.2 |
| Current liabilities | 51.3 | 20.8 |
| Accounts payable | 13.0 | 13.5 |
| Total debt | 10.9 | 11.5 |
| Total liabilities | 63.5 | 33.5 |
| Total equity (incl. minority) | 374 | 126 |
| Retained earnings | 267 | 22.0 |
| Minority interest | 0.0 | — |